Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Cervical Cancer

  Free Subscription


2 Acta Cytol
1 Am Fam Physician
1 Am J Transl Res
1 Anticancer Res
1 Artif Cells Nanomed Biotechnol
1 Brachytherapy
2 Cancer
1 Cancer Cell Int
1 Cancer Epidemiol
1 Cancer Lett
2 Cancer Manag Res
1 Cancer Radiother
1 Cien Saude Colet
1 Crit Rev Oncol Hematol
1 Dose Response
1 Eur J Cancer Prev
1 FEBS Open Bio
1 Future Oncol
1 Gynecol Oncol
1 Gynecol Oncol Rep
1 Int J Prev Med
1 J Am Soc Cytopathol
1 J Clin Microbiol
3 J Contemp Brachytherapy
1 J Gene Med
1 J Int Med Res
1 J Med Screen
1 J Minim Invasive Gynecol
2 J Obstet Gynaecol
1 J Obstet Gynaecol Res
2 Lancet Public Health
1 Life Sci
1 Med Phys
1 Med Sci Monit
1 Medicina (Kaunas)
1 Medicine (Baltimore)
1 Obstet Gynecol
1 Oncol Lett
1 Oncol Rep
1 Pathog Dis
1 PLoS One
1 Radiother Oncol
1 Sci Rep
2 Surg Oncol
1 Zhonghua Yu Fang Yi Xue Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Cytol

  1. ALEXANDER C, White M, Maleki Z, Rodriguez EF, et al
    HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
    Acta Cytol. 2019;63:417-423.
    PubMed     Text format     Abstract available

  2. TOYODA S, Kawaguchi R, Kobayashi H
    Clinicopathological Characteristics of Atypical Glandular Cells Determined by Cervical Cytology in Japan: Survey of Gynecologic Oncology Data from the Obstetrical Gynecological Society of Kinki District, Japan.
    Acta Cytol. 2019;63:361-370.
    PubMed     Text format     Abstract available

    Am Fam Physician

  3. Cervical Cancer, Febrile Seizures, HIV Infection, Dyspepsia.
    Am Fam Physician. 2019;100:331.
    PubMed     Text format    

    Am J Transl Res

  4. WANG X, Zhang J, Wang Y
    Long noncoding RNA GAS5-AS1 suppresses growth and metastasis of cervical cancer by increasing GAS5 stability.
    Am J Transl Res. 2019;11:4909-4921.
    PubMed     Text format     Abstract available

    Anticancer Res

  5. TAMARI K, Sano K, Li Z, Seo Y, et al
    Ro 90-7501 Is a Novel Radiosensitizer for Cervical Cancer Cells that Inhibits ATM Phosphorylation.
    Anticancer Res. 2019;39:4805-4810.
    PubMed     Text format     Abstract available

    Artif Cells Nanomed Biotechnol

  6. DONG Z, Yu C, Rezhiya K, Gulijiahan A, et al
    Downregulation of miR-146a promotes tumorigenesis of cervical cancer stem cells via VEGF/CDC42/PAK1 signaling pathway.
    Artif Cells Nanomed Biotechnol. 2019;47:3711-3719.
    PubMed     Text format     Abstract available


  7. KOBAYASHI D, Okonogi N, Wakatsuki M, Miyasaka Y, et al
    Impact of CT-based brachytherapy in elderly patients with cervical cancer.
    Brachytherapy. 2019 Sep 7. pii: S1538-4721(19)30022.
    PubMed     Text format     Abstract available


  8. ORTIZ AP, Engels EA, Nogueras-Gonzalez GM, Colon-Lopez V, et al
    Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected hispanics living in the United States.
    Cancer. 2018 Oct 22. doi: 10.1002/cncr.31702.
    PubMed     Text format     Abstract available

    Cervical cancer subtype less detectable by Papanicolaou testing.
    Cancer. 2019;125:3287.
    PubMed     Text format    

    Cancer Cell Int

  10. GUO W, Yu H, Zhang L, Chen X, et al
    Effect of hyperoside on cervical cancer cells and transcriptome analysis of differentially expressed genes.
    Cancer Cell Int. 2019;19:235.
    PubMed     Text format     Abstract available

    Cancer Epidemiol

  11. WALTER FM, Moodley JR
    Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa.
    Cancer Epidemiol. 2019 Sep 12:101597. doi: 10.1016/j.canep.2019.101597.
    PubMed     Text format    

    Cancer Lett

  12. FENG S, Liu W, Bai X, Pan W, et al
    LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
    Cancer Lett. 2019;465:105-117.
    PubMed     Text format     Abstract available

    Cancer Manag Res

  13. WANG Y, Han S, You X, Shi X, et al
    The role of low density lipoprotein receptor-related protein 11 as a tumor promoter in cervical cancer.
    Cancer Manag Res. 2019;11:8081-8093.
    PubMed     Text format     Abstract available

  14. YIN Z, Tang H, Li L, Ni J, et al
    Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer.
    Cancer Manag Res. 2019;11:7759-7766.
    PubMed     Text format     Abstract available

    Cancer Radiother

  15. KUMAR T, Achkar S, Haie-Meder C, Chargari C, et al
    [Multimodal imaging guided brachytherapy: the example of cervical cancer].
    Cancer Radiother. 2019 Aug 23. pii: S1278-3218(19)30321.
    PubMed     Text format     Abstract available

    Cien Saude Colet

  16. LOPES VAS, Ribeiro JM
    Cervical cancer control limiting factors and facilitators: a literature review.
    Cien Saude Colet. 2019;24:3431-3442.
    PubMed     Text format     Abstract available

    Crit Rev Oncol Hematol

  17. BOGANI G, Maggiore ULR, Rossetti D, Ditto A, et al
    Advances in laparoscopic surgery for cervical cancer.
    Crit Rev Oncol Hematol. 2019;143:76-80.
    PubMed     Text format     Abstract available

    Dose Response

  18. WANG JM, Wang Y, Huang YQ, Wang H, et al
    Prognostic Values of Platelet-Associated Indicators in Resectable Cervical Cancer.
    Dose Response. 2019;17:1559325819874199.
    PubMed     Text format     Abstract available

    Eur J Cancer Prev

  19. NOWAKOWSKI A, Arbyn M, Turkot MH, Wieszczy P, et al
    A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention.
    Eur J Cancer Prev. 2019 Sep 11. doi: 10.1097/CEJ.0000000000000528.
    PubMed     Text format     Abstract available

    FEBS Open Bio

  20. DING FN, Gao BH, Wu X, Gong CW, et al
    miR-122-5p modulates the radiosensitivity of cervical cancer cells by regulating cell division cycle 25CDC25A.
    FEBS Open Bio. 2019 Sep 10. doi: 10.1002/2211-5463.12730.
    PubMed     Text format     Abstract available

    Future Oncol

  21. WANG Q, Zhang L, Yan Z, Xie L, et al
    OScc: an online survival analysis web server to evaluate the prognostic value of biomarkers in cervical cancer.
    Future Oncol. 2019 Sep 12. doi: 10.2217/fon-2019-0412.
    PubMed     Text format     Abstract available

    Gynecol Oncol

  22. SIMS TT, Colbert LE, Zheng J, Delgado Medrano AY, et al
    Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls.
    Gynecol Oncol. 2019 Sep 6. pii: S0090-8258(19)31489.
    PubMed     Text format     Abstract available

    Gynecol Oncol Rep

  23. COLPAERT C, Jacomen G, Van de Vijver K, Baldewijns M, et al
    Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer? Letter to the editor, Reply to Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questi
    Gynecol Oncol Rep. 2019;29:130-131.
    PubMed     Text format    

    Int J Prev Med

  24. MISHRA GA, Pimple SA, Gupta SD
    Cervical Cancer Screening in Low Resource Settings: Cytology versus HPV Triage for VIA Positive Women.
    Int J Prev Med. 2019;10:138.
    PubMed     Text format     Abstract available

    J Am Soc Cytopathol

  25. HERBERT A, Culora G, McLean E, Kubba AA, et al
    Invasive cervical cancer after treatment of CIN.
    J Am Soc Cytopathol. 2019 Aug 16. pii: S2213-2945(19)30104.
    PubMed     Text format     Abstract available

    J Clin Microbiol

  26. WONG OGW, Ng IFY, Tsun OKL, Pang HH, et al
    Machine learning interpretation of extended human papillomavirus genotyping by Onclarity in an Asian cervical cancer screening population.
    J Clin Microbiol. 2019 Sep 11. pii: JCM.00997-19. doi: 10.1128/JCM.00997.
    PubMed     Text format     Abstract available

    J Contemp Brachytherapy

  27. TANG B, Liu X, Wang X, Kang S, et al
    Dosimetric comparison of graphical optimization and inverse planning simulated annealing for brachytherapy of cervical cancer.
    J Contemp Brachytherapy. 2019;11:379-383.
    PubMed     Text format     Abstract available

  28. PALLED SR, Tanvirpasha CAR, Naveen T, Sathiyan S, et al
    Magnetic resonance image-based 3D volume interstitial brachytherapy using polyether ether ketone catheters in advanced cervical cancer - a feasibility study.
    J Contemp Brachytherapy. 2019;11:307-311.
    PubMed     Text format     Abstract available

  29. MAHANTSHETTY U, Gudi S, Singh R, Sasidharan A, et al
    Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy.
    J Contemp Brachytherapy. 2019;11:293-306.
    PubMed     Text format     Abstract available

    J Gene Med

  30. PULATI N, Zhang Z, Gulimilamu A, Qi X, et al
    HPV16(+) -miRNAs in cervical cancer and miR-5701 plays an anti-tumor role in cervical cancer.
    J Gene Med. 2019 Sep 9:e3126. doi: 10.1002/jgm.3126.
    PubMed     Text format     Abstract available

    J Int Med Res

  31. COSTANTINO C, Mazzucco W, Marotta C, Saporito L, et al
    Methodological issues in a cross-sectional survey on cervical cancer screening using telephone interviews in Sicily (Italy): a SWOT analysis.
    J Int Med Res. 2019 Sep 11:300060519860950. doi: 10.1177/0300060519860950.
    PubMed     Text format    

    J Med Screen

  32. PATEL H, Sherman SM, Tincello D, Moss EL, et al
    Awareness of and attitudes towards cervical cancer prevention among migrant Eastern European women in England.
    J Med Screen. 2019 Sep 12:969141319869957. doi: 10.1177/0969141319869957.
    PubMed     Text format    

    J Minim Invasive Gynecol

  33. VERGOTE I, Magrina JF, Zanagnolo V, Magtibay PM, et al
    The LACC Trial and Minimally Invasive Surgery in Cervical Cancer.
    J Minim Invasive Gynecol. 2019 Sep 11. pii: S1553-4650(19)31178.
    PubMed     Text format    

    J Obstet Gynaecol

  34. GOTTWALD L, Moszynska-Zielinska M, Zytko L, Tomalczyk A, et al
    Prolonged retention of the Lippes loop intrauterine device as a cause of vaginal bleeding 10 years after chemoradiotherapy of locally advanced cervical carcinoma: case report and review of the literature.
    J Obstet Gynaecol. 2019;39:131-132.
    PubMed     Text format    

    Human papillomavirus and cervical cancer.
    J Obstet Gynaecol. 2019 Sep 10:1-7. doi: 10.1080/01443615.2019.1634030.
    PubMed     Text format     Abstract available

    J Obstet Gynaecol Res

  36. KANNO K, Andou M, Yanai S, Toeda M, et al
    Long-term oncological outcomes of minimally invasive radical hysterectomy for early-stage cervical cancer: A retrospective, single-institutional study in the wake of the LACC trial.
    J Obstet Gynaecol Res. 2019 Sep 9. doi: 10.1111/jog.14116.
    PubMed     Text format     Abstract available

    Lancet Public Health

  37. XIA C, Hu S, Xu X, Zhao X, et al
    Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study.
    Lancet Public Health. 2019;4:e462-e472.
    PubMed     Text format     Abstract available

    Reasons for optimism about eliminating cervical cancer in China.
    Lancet Public Health. 2019;4:e434-e435.
    PubMed     Text format    

    Life Sci

  39. DUAN H, Li X, Chen Y, Wang Y, et al
    LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.
    Life Sci. 2019 Sep 13:116856. doi: 10.1016/j.lfs.2019.116856.
    PubMed     Text format     Abstract available

    Med Phys

  40. LU Y, Peng W, Song J, Chen T, et al
    On the potential use of dynamic contrast-enhanced (DCE) MRI parameters as radiomics features of cervical cancer.
    Med Phys. 2019 Sep 16. doi: 10.1002/mp.13821.
    PubMed     Text format     Abstract available

    Med Sci Monit

  41. XIAO S, Xie H, Zhu X, Li X, et al
    Study on the Significance of Folate Receptor-Mediated Staining Solution (FRD) Staining in Screening High Grade Cervical Lesions.
    Med Sci Monit. 2019;25:2792-2801.
    PubMed     Text format     Abstract available

    Medicina (Kaunas)

  42. PAULAUSKIENE J, Ivanauskiene R, Skrodeniene E, Petkeviciene J, et al
    Organised Versus Opportunistic Cervical Cancer Screening in Urban and Rural Regions of Lithuania.
    Medicina (Kaunas). 2019;55.
    PubMed     Text format     Abstract available

    Medicine (Baltimore)

  43. HAILE EL, Cindy S, Ina B, Belay G, et al
    HPV testing on vaginal/cervical nurse-assisted self-samples versus clinician-taken specimens and the HPV prevalence, in Adama Town, Ethiopia.
    Medicine (Baltimore). 2019;98:e16970.
    PubMed     Text format     Abstract available

    Obstet Gynecol

  44. LUCKETT R, Mogowa N, Li HJ, Erlinger A, et al
    Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003496.
    PubMed     Text format     Abstract available

    Oncol Lett

  45. MENDOZA-ALMANZA G, Ortiz-Sanchez E, Rocha-Zavaleta L, Rivas-Santiago C, et al
    Cervical cancer stem cells and other leading factors associated with cervical cancer development.
    Oncol Lett. 2019;18:3423-3432.
    PubMed     Text format     Abstract available

    Oncol Rep

  46. PAPPA KI, Lygirou V, Kontostathi G, Makridakis M, et al
    High resolution analysis of the intracellular proteome of cervical cancer cell lines unveils novel regulators of cervical carcinogenesis.
    Oncol Rep. 2019 Aug 8. doi: 10.3892/or.2019.7269.
    PubMed     Text format     Abstract available

    Pathog Dis

  47. HEMMAT N, Baghi HB
    Association of Human Papillomavirus Infection and Inflammation in Cervical Cancer.
    Pathog Dis. 2019 Sep 2. pii: 5558235. doi: 10.1093.
    PubMed     Text format     Abstract available

    PLoS One

  48. DREYER G, Maske C, Stander M
    Clinical evaluation and budget impact analysis of cervical cancer screening using cobas 4800 HPV screening technology in the public sector of South Africa.
    PLoS One. 2019;14:e0221495.
    PubMed     Text format     Abstract available

    Radiother Oncol

  49. MAHANTSHETTY U, Sturdza A, Naga Ch P, Berger D, et al
    Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome.
    Radiother Oncol. 2019 Sep 5. pii: S0167-8140(19)33043.
    PubMed     Text format     Abstract available

    Sci Rep

  50. JOO J, Omae Y, Hitomi Y, Park B, et al
    The association of integration patterns of human papilloma virus and single nucleotide polymorphisms on immune- or DNA repair-related genes in cervical cancer patients.
    Sci Rep. 2019;9:13132.
    PubMed     Text format     Abstract available

    Surg Oncol

  51. BENDIFALLAH S, de Foucher T, Bricou A, Ouldamer L, et al
    Cervical cancer recurrence: Proposal for a classification based on anatomical dissemination pathways and prognosis.
    Surg Oncol. 2019;30:40-46.
    PubMed     Text format     Abstract available

  52. DUMONT F, Duchalais E, Joseph S, Thibaudeau E, et al
    Laparoscopic total pelvic exenteration via an extraperitoneal approach.
    Surg Oncol. 2019;28:109.
    PubMed     Text format    

    Zhonghua Yu Fang Yi Xue Za Zhi

  53. BI ZF, Li YF, Wei FX, Su YY, et al
    [Introduction of papillomavirus rapid interface for modelling and economics (PRIME) and an example of China's data analysis].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53:744-751.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.